2016 American Transplant Congress

Monday, June 13, 2016

3:42pm-3:54pm

Role of Cardiac Evaluation and Management in Kidney and Liver Transplant Candidates.

W. Bannister, C. Wu, M. Schnitzler, A. Bonagura, B. Laihinen, F. Irwin.

Concurrent Session: Novel Predictors of Outcome, Big Data and Technology  •  Room 302

3:42pm-3:54pm

Targeting IFN-g-Expressing TIM-4⁺ B Effector (Beff) Cells as a Novel Strategy to Prevent Allograft Rejection.

Q. Ding,¹ K. Mohib,¹ S. Xiao,² V. Kuchroo,² D. Rothstein.¹

Concurrent Session: B Cells in Rejection and Tolerance: Animal Models  •  Room 310

3:54pm-4:06pm

Initial Experience with Donor Specific Tregs in Kidney Transplantation.

J. Markmann,¹ E. Guinan,² E. Geissler,³ G. Cole,² S. Germana,¹ J. Kim,¹ B. Sawitzki.⁴

Concurrent Session: Clinical Science: Tolerance: Clinical Studies  •  Room 304

4:30pm-4:42pm

A Pathway to Belatacept Monotherapy: Alemtuzumab, Belatacept and Rapamycin for Kidney Transplantation.

A. Guasch,¹ H. Xu,² A. Mehta,¹ A. Ghali,¹ S. Mead,¹ H. Gebel,¹ R. Bray,¹ C. Larsen,¹ T. Pearson,¹ A. Kirk.²

Concurrent Session: Belatacept and Steroid Withdrawal in Kidney Transplantation  •  Ballroom A

4:30pm-4:42pm

A Prospective Carfilzomib-Based Desensitization Trial: Phase 1 Results.

S. Tremblay,¹ A. Shields,¹ R. Alloway,¹ P. Brailey,¹ B. Abu Jawdeh,¹ T. Latif,¹ J. Driscoll,¹ M. Pando,² A. Girnita,¹ E. Woodle.¹

Concurrent Session: Kidney: Desensitization  •  Room 304

4:30pm-4:42pm

CD4 T Cell Mediated Help Is Required for Intra-Allograft Proliferation of Endogenous Memory CD8 T Cells and Their Ability to Mediate Rejection of Cardiac Allografts Subjected to Prolonged Ischemia.

H. Tsuda, T. Tanaka, C. Su, A. Valujskikh, R. Fairchild.

Concurrent Session: Challenges to Graft Survival and Tolerance: Animal Models  •  Room 306

4:30pm-4:42pm

CMV Immune Monitoring with a CMV ELISPOT Test in Kidney Transplant Patients.

S. Ball, A. Small, C. Waite.

Concurrent Session: CMV: Immune Monitoring & MicroRNA Responses  •  Room 306

4:30pm-4:42pm

De Novo Anti-HLA DSA Characteristics and Subclinical Antibody Mediated Kidney Allograft Injuries.

T. Yamamoto, Y. Watarai, A. Takeda, M. Okada, M. Tsujita, T. Hiramitsu, N. Goto, S. Narumi, K. Morozumi, K. Uchida, T. Kobayashi.

Concurrent Session: Antibody Mediated Rejection in Kidney Transplantation: De Novo DSA  •  Ballroom B

4:30pm-4:42pm

Denosumab Prevents Bone Mineral Density Loss in De Novo Kidney Transplant Recipients: Results from a Randomized Controlled Trial.

M. Bonani,¹ D. Frey,² J. Brockmann,³ T. Fehr,¹ T. Müller,¹ N. Graf,⁴ R. Wüthrich.¹

Concurrent Session: Metabolic Complications in Kidney Transplantation  •  Room 312

4:30pm-4:42pm

Increased Waitlist Death and Removal in Pediatric Liver Transplant Recipients Denied Exception Requests.

H. Braun,³ J. Dodge,² S. Rhee,¹ J. Roberts,² E. Perito.¹

Concurrent Session: Pediatric Liver Transplant  •  Room 206